Down-regulation of tnf-alpha by small interfering rna inhibits particle-induced inflammation in vitro

Artificial Organs

Volumn 35, Issue 7, 2011, Pages 706-714

  Qin, Chu qiang ^a   Ding, Yue ^a   Huang, Dong sheng ^a   Xu, Jie ^a   Ma, Ruo fan ^a   Huang, Jian bin ^a  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hip arthroplasty; Periprosthetic osteolysis; RNA interference; Wear particle

Indexed keywords

ARTHROPLASTY; CELL CULTURE; FLUORESCENCE MICROSCOPY; LIPOSOMES; MACROPHAGES; ORTHOPEDICS; POLYETHYLENES; POLYMERASE CHAIN REACTION; RNA; TITANIUM;

CERAMICS PARTICLES; DOWN-REGULATION; HIP ARTHROPLASTIES; INHIBITORY EFFECT; PERIPROSTHETIC OSTEOLYSIS; RAW 264.7 CELLS; RNA INTERFERENCE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR-ALPHA; WEAR PARTICLES;

PROTEINS;

GREEN FLUORESCENT PROTEIN; POLYETHYLENE; SMALL INTERFERING RNA; TITANIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CERAMICS; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENE SILENCING; IN VITRO STUDY; INTERMETHOD COMPARISON; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY;

MURINAE;

EID: 79960225927     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01175.x     Document Type: Article

References (23)

1. Fender D, Harper WM, Gregg PJ. The Trent regional arthroplasty study. Experiences with a hip register. J Bone Joint Surg Br 2000;82:944-7.
2. Nam KW, Yoo JJ, Lae KY, Kim YM, Lee MH, Kim HJ. Alumina-debris-induced osteolysis in contemporary alumina-on-alumina total hip arthroplasty. A case report. J Bone Joint Surg Am 2007;89:2499-503.
3. Warme BA, Epstein NJ, Trindade MC, etal. Proinflammatory mediator expression in a novel murine model of titanium-particle-induced intramedullary inflammation. J Biomed Mater Res B Appl Biomater 2004;71:360-6.
4. Yang SY, Wu B, Mayton L, etal. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther 2004;11:483-91.
5. Saleh KJ, Thongtrangan I, Schwarz EM. Osteolysis: medical and surgical approaches. Clin Orthop Relat Res 2004;427:138-47.
6. Beraudi A, Stea S, Cremonini S, Visentin M, Toni A. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty. Artif Organs 2009;33:538-43.
7. Xu JW, Konttinen YT, Lassus J, etal. Tumor necrosis factor-alpha (TNF-alpha) in loosening of total hip replacement (THR). Clin Exp Rheumatol 1996;14:643-8.
8. Clohisy JC, Teitelbaum S, Chen S, Erdmann JM, Abu-Amer Y. Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells. J Orthop Res 2002;20:174-81.
9. Bierbaum BE, Nairus J, Kuesis D, Morrison JC, Ward D. Ceramic-on-ceramic bearings in total hip arthroplasty. Clin Orthop Relat Res 2002;405:158-63.
10. Boyce BF, Li P, Yao Z, etal. TNF-alpha and pathologic bone resorption. Keio J Med 2005;54:127-31.
11. Desai SB, Furst DE. Problems encountered during anti-tumour necrosis factor therapy. Best Pract Res Clin Rheumatol 2006;20:757-90.
12. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11.
13. Yang M, Mattes J. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol Ther 2008;117:94-104.
14. Taki N, Tatro JM, Lowe R, Goldberg VM, Greenfield EM. Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. Bone 2007;40:1276-83.
15. Liu F, Zhu Z, Mao Y, Liu M, Tang T, Qiu S. Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide. Biomaterials 2009;30:1756-62.
16. Ren WP, Markel DC, Zhang R, etal. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials 2006;27:5161-9.
17. Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov 2003;2:736-46.
18. Chamekh M, Phalipon A, Quertainmont R, Salmon I, Sansonetti P, Allaoui A. Delivery of biologically active anti-inflammatory cytokines IL-10 and IL-1ra in vivo by the Shigella type III secretion apparatus. J Immunol 2008;180:4292-8.
19. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-85.
20. Persengiev SP, Zhu X, Green MR. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). Rna 2004;10:12-18.
21. McManus MT, Haines BB, Dillon CP, etal. Small interfering RNA-mediated gene silencing in T lymphocytes. J Immunol 2002;169:5754-60.
22. Yang JP, Huang L. Time-dependent maturation of cationic liposome-DNA complex for serum resistance. Gene Ther 1998;5:380-7.
23. Pettit AR, Ji H, von Stechow D, etal. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001;159:1689-99.